Interpace Biosciences Inc año OPV
¿Qué es el año OPV de Interpace Biosciences Inc?
El año OPV de Interpace Biosciences Inc es 1998
¿Cuál es la definición de año OPV?
La oferta pública inicial es un tipo de oferta pública en la cual las acciones de una compañía generalmente se venden a inversionistas institucionales que, a su vez, venden al público en general, en una bolsa de valores, por primera vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
año OPV de compañías en Sector Health Care en NASDAQ en comparadas con Interpace Biosciences Inc
¿Qué hace Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas con año opv similar a Interpace Biosciences Inc
- Rimfire Pacific Mining NL tiene año OPV de 1997
- Flagstar tiene año OPV de 1997
- Active PLC tiene año OPV de 1997
- Redflex tiene año OPV de 1997
- Norwest NL tiene año OPV de 1997
- Kaleyra Inc tiene año OPV de 1997
- Interpace Biosciences Inc tiene año OPV de 1998
- Tuesday Morning tiene año OPV de 1999
- American Axle & Manufacturing Inc tiene año OPV de 1999
- Liontrust Asset Management Plc tiene año OPV de 1999
- Empire Petroleum tiene año OPV de 1999
- Surefire Resources NL tiene año OPV de 1999
- NXT Solutions tiene año OPV de 1999